Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Sales (2016 - 2025)

Historic Return on Sales for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to 0.13%.

  • Haemonetics' Return on Sales rose 200.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.13%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.12% for FY2025, which is 300.0% up from last year.
  • Latest data reveals that Haemonetics reported Return on Sales of 0.13% as of Q4 2025, which was up 200.0% from 0.12% recorded in Q3 2025.
  • Haemonetics' Return on Sales' 5-year high stood at 0.18% during Q1 2025, with a 5-year trough of 0.05% in Q2 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.1% (2023), whereas its average is 0.09%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -1700bps in 2021, then surged by 1200bps in 2025.
  • Over the past 5 years, Haemonetics' Return on Sales (Quarter) stood at 0.06% in 2021, then skyrocketed by 75bps to 0.11% in 2022, then dropped by -14bps to 0.09% in 2023, then increased by 16bps to 0.11% in 2024, then rose by 23bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q4 2025, compared to 0.12% in Q3 2025 and 0.11% in Q2 2025.